Jeff Yass’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
Other funds holding TSHA
Jeff Yass's TSHA Position: Q3 2026 in Review
Jeff Yass increased its Taysha Gene Therapies (TSHA) stake by 2,449% in Q3 2026, buying an estimated $3.83M and bringing the position to 692,416 shares worth $3.37M. The position accounts for ﹤0.01% of the portfolio, ranked #5177.
Jeff Yass first reported a position in TSHA in Q2 2022 and has held it in 16 quarters since. The position peaked at $3.76M in Q1 2024. 203 funds tracked by Wall St. Rank hold TSHA as of Q3 2026.
- Jeff Yass held 692,416 shares of Taysha Gene Therapies worth $3.37M as of Q3 2026.
- Jeff Yass bought 665,252 Taysha Gene Therapies shares in Q3 2026, an estimated $3.83M.
- Taysha Gene Therapies made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #5177 holding.
- Jeff Yass first reported a position in Taysha Gene Therapies in Q2 2022 and has held it in 16 quarters since.
- Jeff Yass's Taysha Gene Therapies position peaked at $3.76M in Q1 2024.
- 203 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.